Entries of Agaimy, A. on the publication server
 | Up a level |
Number of items: 4.
2012
Brookman-May, S., Burger, M., May, M., Denzinger, S., Gierth, M., Siegert, S., Giedl, J., Agaimy, A., Wirth, M.P., Hofstädter, F., Wieland, W.F., Hartmann, A. and Fritsche, H.M.
(2012)
558 Perinodal lymphovascular invasion displays the strongest predictor for cancer-specific mortality in lymph node positive patients with urothelial carcinoma of the bladder.
European Urology Supplements 11 (1), e558-e558a.
Fulltext not available.
2010
Quint, K., Agaimy, A., Steindorf, C., Hellerbrand, C. and Ocker, M.
(2010)
582 EXPRESSION OF HDAC ISOENZYMES AS A PROGNOSTIC MARKER IN HEPATOCELLULAR CARCINOMA.
Journal of Hepatology 52, S230.
Fulltext not available.
Quint, K., Agaimy, A., Hellerbrand, C., Neureiter, D. and Ocker, M.
(2010)
723 Expression of HDAC1, 2, 3 and 7 as a prognostic markers in hepatocellular carcinoma.
European Journal of Cancer Supplements 8 (5), pp. 182-183.
Fulltext not available.
2009
Schwarz, S., Stiegler, C., Zenk, J., Iro, H. and Agaimy, A.
(2009)
Mukoepidermoidkarzinom der Speicheldrüse.
Der Pathologe 30 (6), pp. 472-477.
Fulltext not available.